Manufacturing, Gene Therapies

Testing for Adventitious Agents in Viral Vector Production

October 05, 2022

Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.

Choosing the Right CDMO for CGT Programs

October 02, 2022

Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.

Growth in Cell and Gene Therapy Market

October 02, 2022

Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.

Charles River and Cure AP-4 Announce Manufacturing Collaboration

September 09, 2022

Charles River Laboratories and Cure AP-4 will collaborate on gene therapy manufacturing for AP-4 hereditary spastic paraplegia.

Forecyte Bio and Cytiva to Collaborate on Cell and Gene Therapy Manufacturing and Development

August 31, 2022

Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.

Pfizer and Touchlight Enter Patent License Agreement for Use of dbDNA

July 13, 2022

Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.

Drug Digest: Development and Scalability of ADCs and CGTs

July 07, 2022

In this exclusive Drug Digest video, experts from Roche and MilliporeSigma divulge factors that could influence an organization to pursue specific biomolecules for development.

REGENXBIO Launches New Gene Therapy Manufacturing Facility in US

June 13, 2022

REGENXBIO has opened a new in-house facility at its headquarters in Rockville, Md., that will be used to manufacture AAV gene therapies at commercial scale.

Astellas Opens New US-based Large-Scale Gene Therapy Manufacturing Facility

June 10, 2022

Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.

Lilly to Invest $2.1 Billion in New Indiana Manufacturing Facilities

June 08, 2022

Eli Lilly and Company plans to build two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.